Free Trial
TSE:SVA

Sernova (SVA) Stock Price, News & Analysis

Sernova logo
C$0.12 +0.01 (+4.55%)
As of 10:56 AM Eastern

About Sernova Stock (TSE:SVA)

Advanced

Key Stats

Today's Range
C$0.12
▼
C$0.12
50-Day Range
C$0.09
▼
C$0.14
52-Week Range
C$0.09
▼
C$0.20
Volume
19,990 shs
Average Volume
151,553 shs
Market Capitalization
C$43.43 million
P/E Ratio
N/A
Dividend Yield
7.86%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.

Receive SVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SVA Stock News Headlines

Wall Street legend reveals his top AI stock before Oct. 20
Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock ahead of October 20. His system has spotted at least seven of the top 10 performers every year since 2016, including all ten in the 2022 bear market and every member of the Magnificent Seven before their run higher. Now Chaikin's Power Gauge is turning bullish on an under-the-radar company tied to next-generation AI data centers built under Executive Order 14363, technology he says uses 99 percent less electricity and space while offering far greater computing power.tc pixel
SERNOVA BIOTHERAPEUTICS INC
See More Headlines

SVA Stock Analysis - Frequently Asked Questions

Sernova's stock was trading at C$0.13 on January 1st, 2026. Since then, SVA stock has decreased by 11.5% and is now trading at C$0.12.

Sernova Corp. (TSE:SVA) issued its quarterly earnings data on Thursday, September, 10th. The company reported ($0.01) earnings per share (EPS) for the quarter.

Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sernova investors own include Sernova Biotherapeutics (SEOVF), Intel (INTC), CloudMD Software & Services (DOC), Advanced Micro Devices (AMD), Apellis Pharmaceuticals (APLS), Cidara Therapeutics (CDTX) and ARC Resources (ARX).

Company Calendar

Last Earnings
9/10/2026
Today
10/14/2026

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
TSE:SVA
CIK
N/A
Fax
N/A
Employees
1,959
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$35.70 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
57.10%
Return on Assets
-119.26%

Debt

Debt-to-Equity Ratio
-21.98
Current Ratio
0.03
Quick Ratio
18.11

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.02 per share
Price / Cash Flow
6.15
Book Value
C($0.03) per share
Price / Book
-3.69

Miscellaneous

Outstanding Shares
377,643,000
Free Float
N/A
Market Cap
C$43.43 million
Optionable
Not Optionable
Beta
-0.47
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (TSE:SVA) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners